Australia seems poised to experience innovative treatment for weight issues: Retatrutide. The dual compound – acting on both GLP-1 and GIP receptors – demonstrates remarkable efficacy in international trials, indicating substantial drops in body fat. While approval is pending with the Therapeutic Goods Administration (TGA), a number of individu